With a discussion on cell line productivity and evolution, an exploration of the benefits of utilizing molecule optimization and engineering, and an overview of how Resilience is aiming to reduce manufacturing timelines by 30% from drug ideation to first-in-human trials, you won’t want to miss this presentation.
Milan Tomic, Senior Director of Process Development at Resilience, shared his expertise June 4, 2024, during the BIO International Convention in San Diego. Milan provided an informative presentation within the BIO Company Presentation Theater focused on improving cell line development in CHO with a focus on product manufacturability.
If you happened to miss the presentation live, access it below on demand!